Kyverna Therapeutics Inc (NAS:KYTX)
$ 8.88 +0.44 (+5.21%) Market Cap: 539.56 Mil Enterprise Value: 336.87 Mil PE Ratio: 0 PB Ratio: 2.75 GF Score: 12/100

Kyverna Therapeutics Inc Annual Shareholders Meeting Transcript

May 27, 2026 / 06:00 PM GMT
Release Date Price: $8.59 (-0.23%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

KYTX.OQ - Kyverna Therapeutics Inc
Kyverna Therapeutics Inc Annual Shareholders Meeting
May 27, 2026 / 06:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, thank you for standing by, and welcome to the Kyverna Therapeutics, Inc. Annual Meeting.

I'll now turn the conference over to Warner Biddle. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you. Good morning, ladies and gentlemen. Welcome to the 2026 Annual Meeting of Stockholders of Kyverna Therapeutics. I'm Warner Biddle, the company's CEO.

2026 marks a pivotal inflection year for Kyverna as we transition to a commercial-stage company supported by strong clinical execution and significant regulatory
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot